pulmonaryfibrosisnews8h
Runx2 protein may be treatment target for pulmonary fibrosis
A protein called Runx2 contributes to the abnormal activity of lung cells that drive pulmonary fibrosis, a new study shows.
Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarring
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...
technologynetworks1d
Targeting Immune Cell Proteins To Reverse Lung Scarring
Researchers at Duke-NUS Medical School have identified YAP and TAZ proteins as key drivers of pulmonary fibrosis. Blocking ...
Sign of fatal disease that shows on fingers as NHS warns 'see GP'
The disease can cause it to become harder and harder to breathe - and it's key you keep an eye out for symptoms ...
Health charity warns common 'cough' could actually be fatal disease - 'never assume it's normal'
Specifically, idiopathic pulmonary fibrosis (IPF) is a condition in which the lungs become scarred and breathing becomes ...
BioSpace11d
Pliant Stock Crashes After Suspension of Idiopathic Pulmonary Fibrosis Study
It is unclear why an independent data safety monitoring board recommended the suspension of Pliant’s Phase IIb/III BEACON-IPF ...
pharmaphorum10d
Boehringer drug scores in another pulmonary fibrosis trial
The two positive studies mean that Boehringer can now seek approval for nerandomilast with a broad label claim in pulmonary ...
pulmonaryfibrosisnews7d
Nerandomilast shows promise for progressive pulmonary fibrosis
Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...